Business
Roadman Updates on Acquisition Target CLOV Biopharma Corp.
(via TheNewswire) February 21, 2020 - TheNewswire - VANCOUVER, British Columbia ...
About this update from Futuregen Industries Corp.
[{"type":"text","content":"Roadman Updates on Acquisition Target CLOV Biopharma Corp.(via TheNewswire)\n \n \nFebruary 21, 2020 - TheNewswire - VANCOUVER, British Columbia - Roadman Investments Corp. (TSXV:LITT)(FWB:1QD)(OTC:RMANF) (\"Roadman Investments\" or the \"Company\") is pleased to announce that, the Company's pending acquisition target, CLOV Biopharma Corp. (\"CBP\"), continues to advance its business plan in an effort to expedite its mandate of advancing the research and potential commercial viability of cedar leaf oil vapour specifically in the pharmaceutical, healthcare, and biotechnology sectors. CBP's corporate mission is to conduct further research and development of cedar leaf oil vapour (\"CLOV\") for the purposes of preventing the spread of Coronavirus and other similar potentially pathogenic respiratory viruses, for example, influenza and para-influenza viruses, and respiratory syncytial viruses. Previously published manuscripts authored by CBP's medical scientific advisor Dr. James Hudson, a foremost Canadian virologist, have concluded that, in a laboratory setting, CLOV was effective in killing (inactivating) several human respiratory viruses, including Influenza virus, Rhinovirus, Adenovirus, as well as Herpes simplex virus. It was also shown that short-term exposure to CLOV had no adverse effect on cultured lung epithelial cells, thus confirming it is not cytotoxic. Further, it was shown that CLOV also partly reversed the pro-inflammatory effect caused by Rhinovirus infection, which means that it acts as a multifunctional therapeutic agent. \n\n \n \nCBP has identified a number of diffusers that it believes will be functional with cedar leaf oil and cedar leaf oil vapour and, as such, it intends to begin testing these diffusers immediately. Portable, hand-held, and stationary diffusers have been identified as functional candidates for further testing. Previously, both anecdotal, and laboratory confirmed tests obtained via in field studies in a commercial domicile setting have shown that both mould and bacteria levels had dropped significantly when diffused CLOV was present in the air. Additionally, a 2010 research project by Dr. Hudson showed that cedar leaf oil vapour killed the top medically important antimicrobial resistant organisms that are responsible for hospital-acquired infections. It is the intent of CLOV Biopharma Corp. t...